| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $44.7M | — |
| R&D Expense | $42.4M | +107.9% |
| SG&A Expense | $6.4M | -74.5% |
| Operating Income | -$4.0M | +91.1% |
| Interest Expense | $19K | -99.3% |
| Pre-tax Income | $850K | +101.7% |
| Income Tax | -$4.5M | — |
| Net Income | $5.3M | +110.5% |
| EPS (Basic) | $0.14 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $194.4M | -9.2% |
| Accounts Receivable | $323K | +1515.0% |
| Current Assets | $213.0M | -6.1% |
| Total Assets | $270.2M | -3.7% |
| Current Liabilities | $12.2M | +9.7% |
| Total Liabilities | $27.0M | -4.1% |
| Stockholders' Equity | $242.9M | -3.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$14.4M | +55.7% |
| Capital Expenditures | $6.1M | +435.6% |
| Investing Cash Flow | -$5.8M | +55.5% |
| Financing Cash Flow | $325K | -99.9% |
| Free Cash Flow | -$20.6M | +39.0% |
| +107.1% |
| EPS (Diluted) | $0.14 | +107.1% |